Oncomine Breast cfTNA Assay Test sale cost 9600 AED
Carrier Screening Test sale cost 11400 AED Carrier Screening Test 15,200 د.إ 11,400 د.إ
Glucose-6-Phosphate Dehydrogenase G6PD Full-Length Gene Sequence Analysis Test sale cost 9010 AED Glucose-6-Phosphate Dehydrogenase G6PD Full-Length Gene Sequence Analysis Test 10,010 د.إ 9,010 د.إ
Sale!

Oncomine Breast cfTNA Assay Test

9,600 د.إ

-36%

The Oncomine Breast cfTNA Assay Test is a cutting-edge diagnostic tool designed for the detection and analysis of circulating free tumor nucleic acids (cfTNA) in the plasma of patients with breast cancer. This highly sensitive and specific assay is utilized to identify and quantify genetic mutations and alterations in breast cancer DNA, providing critical insights that can guide personalized treatment strategies.

Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the Oncomine Breast cfTNA Assay Test harnesses next-generation sequencing technology to offer a comprehensive genomic profile of a patient’s breast cancer. This non-invasive approach allows for the monitoring of disease progression and response to treatment without the need for traditional, more invasive biopsy methods.

The cost of the Oncomine Breast cfTNA Assay Test at DNA Labs UAE is 9600 AED. While the price may seem high, the value it provides in terms of precise cancer characterization and the potential to tailor treatment plans to individual genetic profiles makes it a valuable tool in the fight against breast cancer. This test represents a significant advancement in oncology, offering hope for improved outcomes through personalized medicine.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Oncomine Breast cfTNA Assay Test

Cost: AED 9600.0

Symptoms, Diagnosis, and Test Details

The Oncomine Breast cfTNA Assay Test is a diagnostic test that is used to detect genetic mutations in cell-free tumor DNA (cfTNA) from the blood of patients with breast cancer. This test analyzes 49 genes commonly mutated in breast cancer, including BRCA1, BRCA2, and TP53, using next-generation sequencing technology.

The test is designed to help physicians identify patients who may benefit from targeted therapies or clinical trials based on their specific genetic mutations. It can also be used to monitor treatment response and disease progression over time.

Unlike traditional tissue biopsies, the Oncomine Breast cfTNA Assay Test is a minimally invasive alternative that does not require painful procedures or recovery time. Additionally, it is faster and less expensive than traditional genetic testing methods, allowing for more efficient and personalized treatment options for patients with breast cancer.

Test Components

  • Streak Tube

Price

AED 9600.0

Sample Condition

Peripheral blood (10 ml.)

Report Delivery

2-3 weeks

Method

Next-Generation Sequencing (NGS)

Test Type

Genetics

Doctor

General Physician

Test Department

Pre Test Information

The Oncomine Breast cfTNA Assay Test can be done with a doctor’s prescription. However, it is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Name Oncomine Breast cfTNA Assay Test
Components Streak Tube
Price 9600.0 AED
Sample Condition Peripheral blood (10 ml.)
Report Delivery 2-3 weeks
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information Oncomine Breast cfTNA Assay can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The Oncomine Breast cfTNA Assay is a diagnostic test that is used to detect genetic mutations in cell-free tumor DNA (cfTNA) from the blood of patients with breast cancer. The assay uses next-generation sequencing technology to analyze 49 genes that are commonly mutated in breast cancer, including BRCA1, BRCA2, and TP53.

The test is designed to help physicians identify patients who may benefit from targeted therapies or clinical trials based on their specific genetic mutations. It can also be used to monitor treatment response and disease progression over time.

The Oncomine Breast cfTNA Assay is a minimally invasive alternative to traditional tissue biopsies, which can be painful and require recovery time. It is also faster and less expensive than traditional genetic testing methods, allowing for more efficient and personalized treatment options for patients with breast cancer.

SKU: TEST-687 Category:

Related products